BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11506299)

  • 1. Analysis of lupus activity in end-stage renal disease treated by hemodialysis.
    Okano K; Yumura W; Nitta K; Uchida K; Ohnuki T; Kawashima A; Nihei H
    Intern Med; 2001 Jul; 40(7):598-602. PubMed ID: 11506299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with active systemic lupus erythematosus after endstage renal disease.
    Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
    J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent lupus activity in end-stage renal disease.
    Krane NK; Burjak K; Archie M; O'donovan R
    Am J Kidney Dis; 1999 May; 33(5):872-9. PubMed ID: 10213642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment with Belimumab in a Patient with Refractory Systemic Lupus Erythematosus after Initiation of Hemodialysis: Considering the Synergistic Effect of Belimumab and Immunological Burn-Out Phenomenon in End-Stage Renal Disease Patients on Hemodialysis.
    Karasawa K; Ogura S; Takabe T; Miyabe Y; Iwabuchi Y; Akiyama K; Sato M; Moriyama T; Uchida K; Nitta K
    Blood Purif; 2022; 51(2):182-188. PubMed ID: 33895749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.
    Barrera-Vargas A; Quintanar-Martínez M; Merayo-Chalico J; Alcocer-Varela J; Gómez-Martín D
    Rheumatology (Oxford); 2016 Mar; 55(3):429-35. PubMed ID: 26396262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Flare of Systemic Lupus Erythematosus in Patients With Endstage Renal Disease on Dialysis.
    Kim YE; Choi SJ; Lim DH; Kim H; Ahn SM; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    J Rheumatol; 2022 Oct; 49(10):1131-1137. PubMed ID: 35970534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of end-stage renal disease due to lupus nephritis: comparison of six patients treated with both peritoneal and hemodialysis.
    Stock GG; Krane NK
    Adv Perit Dial; 1993; 9():147-51. PubMed ID: 8105910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE.
    Nossent HC; Swaak TJ; Berden JH
    Am J Med; 1990 Aug; 89(2):169-74. PubMed ID: 2382665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.
    Plantinga LC; Lim SS; Patzer RE; Pastan SO; Drenkard C
    BMC Nephrol; 2016 Jul; 17(1):64. PubMed ID: 27388761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease.
    Salgado Guerrero M; Londono Jimenez A; Dobrowolski C; Mowrey WB; Goilav B; Wang S; Broder A
    BMC Nephrol; 2020 Oct; 21(1):450. PubMed ID: 33115441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
    Bruce IN; Hallett DC; Gladman DD; Urowitz MB
    J Rheumatol; 1999 Jul; 26(7):1490-4. PubMed ID: 10405935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive treatment in dialysis patients.
    Altieri P; Sau G; Cao R; Barracca A; Menneas A; Micchittu B; Cabiddu G; Esposito P; Pani A
    Nephrol Dial Transplant; 2002; 17 Suppl 8():2-9. PubMed ID: 12147770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical course of end-stage renal disease in systemic lupus erythematosus.
    Jarrett MP; Santhanam S; Del Greco F
    Arch Intern Med; 1983 Jul; 143(7):1353-6. PubMed ID: 6870409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature.
    Mattos P; Santiago MB
    Clin Rheumatol; 2012 Jun; 31(6):897-905. PubMed ID: 22415467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities.
    Pahl MV; Vaziri ND; Saiki JK; Upham T; Ness R
    Artif Organs; 1984 Nov; 8(4):423-8. PubMed ID: 6334509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus in patients with chronic renal failure.
    Cheigh JS; Stenzel KH; Rubin AL; Chami J; Sullivan JF
    Am J Med; 1983 Oct; 75(4):602-6. PubMed ID: 6353915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort.
    Ribeiro FM; Leite MA; Velarde GC; Fabris CL; Santos RC; Lugon JR
    Am J Nephrol; 2005; 25(6):596-603. PubMed ID: 16282677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis.
    Goo YS; Park HC; Choi HY; Kim BS; Park YB; Lee SK; Kang SW; Kim SI; Kim YS; Park KI; Lee HY; Han DS; Choi KH
    Yonsei Med J; 2004 Apr; 45(2):199-206. PubMed ID: 15118989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients.
    Lee PT; Fang HC; Chen CL; Chiou YH; Chou KJ; Chung HM
    Lupus; 2003; 12(11):827-32. PubMed ID: 14667098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.